At a glance
- Originator Ono Pharmaceutical
- Class Phenyl ethers; Small molecules
- Mechanism of Action Matrix metalloproteinase inhibitors; Metalloprotease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Endometriosis; Inflammatory bowel diseases; Osteoarthritis
Most Recent Events
- 18 May 2005 Discontinued - Phase-I for Inflammatory bowel disease in Japan (PO)
- 18 May 2005 Discontinued - Phase-I for Inflammatory bowel disease in United Kingdom (PO)
- 18 May 2005 Discontinued - Phase-I for Osteoarthritis in Japan (PO)